Skip to content

EPT 100: Geranium Oil for the Relief of Neuropathic Pain

EPT 100: Geranium Oil for the Relief of Neuropathic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01007747
Acronym
Geranium Oil
Enrollment
166
Registered
2009-11-04
Start date
2008-11-30
Completion date
2011-10-31
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain

Keywords

Geranium oil, Neuropathy

Brief summary

The purpose of this study is to determine if Geranium oil will relieve a variety of neuropathic pain and some pain relief will last more than 48 hours.

Detailed description

EPT 100 study is designed to identify the percentage of people who experience neuropathic pain relief from topical geranium oil from Reunion Island, determine which neuropathic pain conditions respond best and define the time course of the pain relief.

Interventions

Daily topical application over neuropathic pain

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or oler * Neuralgia or neuropathy with daily pain * At least moderate intensity pain * Signed informed consent

Exclusion criteria

* Pregnant or nursing * Known allergies to geranium oil or geranium oil fractions

Design outcomes

Primary

MeasureTime frame
Pain relief3 times in 30 to 60 minutes post-application

Secondary

MeasureTime frame
Response to therapy at 30 to 60 minutes, they will be asked to apply the oil to painful area dailyDaily over 1 week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026